Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03044093
Other study ID # 0299-16-RMB
Secondary ID
Status Recruiting
Phase Phase 4
First received January 18, 2017
Last updated February 2, 2017
Start date January 2017
Est. completion date January 2019

Study information

Verified date February 2017
Source Rambam Health Care Campus
Contact MEIR NIZRI, MD
Phone 972-50-2061521
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Mifepristone and Misoprostol Compared With Misoprostol Alone for Second Trimester Abortion - a Double Blinded Randomized Controlled Trial


Recruitment information / eligibility

Status Recruiting
Enrollment 200
Est. completion date January 2019
Est. primary completion date January 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria:

- healthy

- no allergy known to these drugs

- second trimester abortion

Exclusion Criteria:

- hematology diseases

- clotting factor deficiency

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Mifepristone
The group that will get in addition to Misoprostol also Mifepristone
Placebo
The group that will only get Misoprostol
Misoprostol
Both groups will get think drug

Locations

Country Name City State
Israel Rambam Medical Campus Haifa

Sponsors (1)

Lead Sponsor Collaborator
Rambam Health Care Campus

Country where clinical trial is conducted

Israel, 

Outcome

Type Measure Description Time frame Safety issue
Primary Reduction in Hospital Stay Duration number of days of hospital stay Up to 24 months
See also
  Status Clinical Trial Phase
Terminated NCT04063904 - Pilot Study of an Ambulatory Medical Abortion Service at 13-18 Weeks of Gestation in Colombia Phase 4
Completed NCT03400358 - Uterocervical Angle in the Pregnancy Termination of Multiparous Women N/A
Recruiting NCT04501809 - Second Trimester Pregnancy Termination in Women With Previous Caesarean Sections N/A
Enrolling by invitation NCT06078501 - MisOpRostol Effect on Second Trimester Abortion Blood Loss Phase 3
Completed NCT04181541 - Midlevel Versus Physician-provided Medical Abortion in the Second Trimester N/A
Completed NCT06164067 - The Role of Cervical Consistency Index and Uterocervical Angles in Medical Termination
Completed NCT02033083 - Laminaria Compared to Dilapan-S for Cervical Preparation Before Dilation and Evacuation at 18-24 Weeks of Gestation N/A
Recruiting NCT06123026 - Pharmacological Inhibition of Lactation After 16 to 20 Week Abortion Phase 4
Terminated NCT03714880 - Cervical Preparation With Mifepristone Prior to Osmotic Dilators Phase 2
Completed NCT03407521 - Misoprosotol and Isosorbide Mononitrate for Induction of Second Trimester Abortion Phase 4